Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2008
11/13/2008US20080279929 Nanoparticulate and Controlled Release Compositions Comprising Cefditoren
11/13/2008US20080279923 Use of Microtubule Stabilizing Compounds for the Treatment of Lesions of Cns Axons
11/13/2008US20080279906 Intracellular delivery of endothelial growth factor
11/13/2008US20080279895 Therapy or prevention of headaches; administering neurotoxin by injection
11/13/2008US20080279873 Active immunization to generate antibodies to soluble a-beta
11/13/2008US20080279869 Method for reducing neuronal degeneration by administering cns-derived peptides or activated t cells
11/13/2008US20080279864 High Throughput Screen Utilizing Newly Discovered Intramolecular Neuronal Calcium Channel Interactions To Discover New Analgesics
11/13/2008US20080279859 Neurite outgrowth inhibitor -66 receptor (NOGO-66) specific monoclonal antibody for treatment and prevention of nervous system, muscular, tumor and vision disorders
11/13/2008US20080279846 lipoprotein-associated phospholipase A2 (Lp-PLA2)
11/13/2008US20080279841 Novel Therapeutic Molecular Variants And Uses Thereof
11/13/2008US20080279822 Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand
11/13/2008US20080279819 Therapeutic mixture comprising uncompetitive n-methylaspartic acid receptor antagonist, glatiramer acetate and monoclonal antibody for use in treatment of multiple sclerosis
11/13/2008US20080279814 Using interleukin-5 mixture as therapeutic tool in treatment of nervous system disorders
11/13/2008US20080279784 Nasal administration of benzodiazepines
11/13/2008US20080279775 Benztropinamine Analogs as Dopamine Uptake Inhibitors
11/13/2008DE10362194B4 Verfahren zum Testen der Aktivität einer möglichen wirksamen Substanz, die die enzymatische Aktivität der Phospholipase A2 hemmen kann A method for testing the activity of a possible active substance which inhibit the enzymatic activity of phospholipase A2 can
11/13/2008DE102007022007A1 Neuartike Pharmazeutika, Verfahren zu ihrer Herstellung und ihre Verwendung in der Prophylaxe und Therapie von ZNS-Erkrankungen und Diabetes Neuartike pharmaceuticals, to processes for their preparation and their use in the prophylaxis and treatment of CNS disorders and diabetes
11/13/2008DE102007021549A1 Transdermales therapeutisches System enthaltend mindestens zwei Opioide Transdermal therapeutic system containing at least two opioids
11/13/2008DE102007019417A1 Tapentadol zur Schmerzbehandlung bei Arthrose Tapentadol for pain management in osteoarthritis
11/13/2008CA2809739A1 Morphinan compounds
11/13/2008CA2689608A1 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
11/13/2008CA2686707A1 Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals
11/13/2008CA2686589A1 Gamma secretase modulators
11/13/2008CA2686387A1 1, 3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylase
11/13/2008CA2685924A1 Naphthyl(ethyl)acetamides
11/13/2008CA2685421A1 Oronasopharyngeally deliverable pharmaceutical composition for the prevention/alleviation and/or treatment of restless limb disorder
11/13/2008CA2684953A1 Use of s1p receptor modulator
11/13/2008CA2684703A1 Bicyclic compound and pharmaceutical use thereof
11/12/2008EP1990413A1 Screening method for candidate drugs
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1990341A1 Triazolyl tropane derivatives as CCR5 modulators
11/12/2008EP1990058A1 Aglyco products and their use for inhibiting infection by influenza virus, and useof hexosamine precursor in schizophrenia treatment
11/12/2008EP1990053A1 Pharmaceutical composition for enhancing adiponectin production
11/12/2008EP1990051A1 Combinations of SSRI and estrogenic agents
11/12/2008EP1990049A2 Combination therapy of beta-blockers and non-steroidal anti-inflammatory drugs (NSAID)
11/12/2008EP1990047A1 Use of a monoterpene to treat or prevent stress
11/12/2008EP1990046A1 Condensation aerosol containing loxapine or prochlorperazine for inhalation
11/12/2008EP1989308A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases
11/12/2008EP1989210A2 A2a adenosine receptor antagonists
11/12/2008EP1989208A1 New morphine compounds for pharmaceutical compositions
11/12/2008EP1989197A1 Pyrazolylquinazolinones as potassium channel openers
11/12/2008EP1989195A1 Phosphodiesterase 10 inhibitors
11/12/2008EP1989188A1 Therapeutic piperazines as pde4 inhibitors
11/12/2008EP1989185A1 Therapeutic compounds
11/12/2008EP1988971A2 Compositions and methods for preserving brain function
11/12/2008EP1988916A1 Methods and agents for reducing oxidative stress
11/12/2008EP1988904A2 Sustained-release formulation comprising a glucuronate salt of a piperazine compound and uses thereof
11/12/2008EP1988902A2 Piperazine derivatives
11/12/2008EP1988898A2 Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin
11/12/2008EP1988892A2 Modulators of muscarinic receptors
11/12/2008EP1988885A2 Combination of organic compounds
11/12/2008EP1988883A1 Novel pharmaceutical compositions for optimizing replacement treatments and broadening the pharmacopeia for the overall treatment of addictions
11/12/2008EP1912976B1 Indol-3-yl-carbonyl-piperidin-benzoimidazole derivatives as v1a receptor antagonists
11/12/2008EP1893597B1 Ampa receptor potentiators
11/12/2008EP1863791B1 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists
11/12/2008EP1751138B9 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/12/2008EP1692143B1 Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of alzheimer's disease
11/12/2008EP1569627B1 Method of treating movement disorders using barbituric acid derivatives
11/12/2008EP1534291B1 2-(phenylthiomethyl)- morpholine derivatives for use as selective norepinephrine reuptake inhibitors
11/12/2008EP1523488B1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
11/12/2008CN101305011A Pyridine derivatives and their use in the treatment of psychotic disorders
11/12/2008CN101305007A Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as PDE5 inhibitors
11/12/2008CN101305004A Novel diazabicyclic aryl derivatives and their medical use
11/12/2008CN101305003A (1-aza-bicyclo[3.3.1] n0n-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-ACHR for the treatment of psychotic and neurodegenerative disorders
11/12/2008CN101304995A Thiazole derivatives and use thereof
11/12/2008CN101304994A 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
11/12/2008CN101304993A Compounds and compositions as ppar modulators
11/12/2008CN101304984A Oxazole and thiazole ppar modulator
11/12/2008CN101304973A Methods of modulating neurotrophin-mediated activity
11/12/2008CN101304970A Amorphous form of 1,2-dihydropyridine compound
11/12/2008CN101304752A Anti-misuse microparticulate oral pharmaceutical form
11/12/2008CN101304745A Diaryl urea for treating diabetic neuropathy
11/12/2008CN101304737A Diaryl urea for treating diabetic neuropathy
11/12/2008CN101302529A Transgenic neural stem cell co-expressing GDNF and BDNF
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101302221A Anti-platelet activating factor compound
11/12/2008CN101302214A Aralkyl piperidine (piperazidine) derivate and use thereof in mental disease treatment
11/12/2008CN101301459A Medicated pillow
11/12/2008CN101301450A Medicament for treating anypnia
11/12/2008CN101301447A Chinese medicinal composition for treating epilepsy
11/12/2008CN101301440A Navel plaster with powder for quieting spirit
11/12/2008CN101301438A Wine companion for promoting digestion, protecting liver and preventing alcoholism
11/12/2008CN101301430A Decoction for treating blood deficiency type neurasthenic
11/12/2008CN101301429A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301410A Fuzheng decoction for facial paralysis
11/12/2008CN101301408A Polygala root and bastard tamarind capsules
11/12/2008CN101301390A Health wine for releasing toxin of cigarette and producing method thereof
11/12/2008CN101301379A Chinese medicinal composition and preparation and use thereof
11/12/2008CN101301357A Use of schisandra chinensis extract in anti-depression medicament
11/12/2008CN101301336A Decoction medicament for treating localized neurodermatitis
11/12/2008CN101301335A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301334A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301333A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301332A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301327A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301326A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301325A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301310A Use of brown alga polysaccharide sulfate in preventing and treating Parkinson's disease
11/12/2008CN101301302A Uses of luteolin-7-O-beta-D glucuronide in preparing medicament for treating dementia
11/12/2008CN101301293A Acidum folicum effervescent tablet and preparation thereof
1 ... 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 ... 1833